Hodgkin Lymphoma Program
Who we are
Dana-Farber/Children's Hospital Cancer Center's Hodgkin Lymphoma Program is led by pediatric experts in hematology/oncology, radiology, pathology and radiation oncology.
If your child has been recently diagnosed with Hodgkin lymphoma, you probably have lots of questions about treatment. If your child has relapsed or hard-to-treat Hodgkin lymphoma, we provide direct access to the newest clinical trials and advanced therapies.
Coming to Dana-Farber/Children's Hospital Cancer Center means your child will be treated by some of the world’s most experienced pediatric oncologists at Dana-Farber Cancer Institute and internationally recognized pediatric subspecialists at Children’s Hospital Boston.
- All members of our team, which includes pediatric oncologists, radiation oncologists, surgeons, interventional and diagnostic radiologists and hematopathologists, have specific expertise in pediatric lymphomas.
- We offer comprehensive diagnosis, treatment, consultation services for children and adolescents.
- We also provide access to multiple clinical trials investigating new treatment approaches, as well as complex therapies like stem cell or bone marrow transplantation.
- Our center offers a long-term care program especially designed for survivors of childhood cancer.
Did you know? Research consortium
Dana-Farber Cancer Institute is a founding member of a small national consortium of leading medical centers that investigates new treatments for children with Hodgkin disease.
Did you know? Discovery of Hodgkin
Hodgkin Lymphoma was first described by Dr. Thomas Hodgkin in 1832. It is one of the first cancers to be successfully treated through chemotherapy and radiation therapy.